Anzeige
❌
Mehr »
Montag, 05.10.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
CA

WKN: A41CM7 | ISIN: US14280C1053 | Ticker-Symbol: I82
Tradegate
02.10.26 | 15:54
12,500 Euro
-1,57 % -0,200
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
CARLSMED INC Chart 1 Jahr
5-Tage-Chart
CARLSMED INC 5-Tage-Chart
RealtimeGeldBriefZeit
12,50012,90009:36
12,50012,90009:18

Aktuelle News zur CARLSMED Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
CARLSMED Aktie jetzt für 0€ handeln
FrCarlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)1
FrCarlsmed names chief product and AI officer as it claims CMS reimbursements-
DoCARLSMED, INC. - S-8, Securities to be offered to employees in employee benefit plans1
DoCarlsmed Appoints Tony Jarc as Chief Product and AI Officer219CARLSBAD, Calif., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions...
► Artikel lesen
MiCARLSMED, INC. - 8-K, Current Report1
28.09.Carlsmed appoints Richard Heppenstall as CFO1
28.09.Carlsmed appoints new CFO, reaffirms 2026 revenue outlook1
28.09.Carlsmed beruft Richard Heppenstall zum neuen CFO2
28.09.Carlsmed Appoints Richard Heppenstall as Chief Financial Officer292CARLSBAD, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions...
► Artikel lesen
16.09.Carlsmed files patent lawsuit against DeGen Medical2
16.09.Carlsmed, Inc. Files Patent Infringement Lawsuit against DeGen Medical136CARLSBAD, Calif., Sept. 15, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed"), a medical technology company pioneering AI-enabled personalized spine surgery solutions, today filed...
► Artikel lesen
08.09.Carlsmed promotes Jeff Bertolini to COO to support spine surgery growth1
08.09.Carlsmed, Inc. Announces Chief Operating Officer Appointment216CARLSBAD, Calif., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions...
► Artikel lesen
08.09.CARLSMED, INC. - 8-K, Current Report2
12.08.Carlsmed auf Konferenz der Bank of America: Bessere Medicare-Vergütung als Wachstumstreiber6
06.08.Truist raises Carlsmed stock price target on strong growth outlook1
06.08.Carlsmed outlines $74M-$78M 2026 revenue outlook as CMS finalizes new aprevo lumbar MS-DRGs effective October 11
05.08.Carlsmed steigert Umsatz im zweiten Quartal 2026 um 57 %, Aktie reagiert kaum1
05.08.Carlsmed Reports Second Quarter 2026 Financial Results and Raises Full-Year Guidance152Second quarter 2026 revenue of $18.9 million, representing 57% growth year-over-year Full year 2026 revenue guidance raised to $74 million to $78 million CARLSBAD, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE)...
► Artikel lesen
03.08.Carlsmed Announces Favorable Reimbursement for aprevo lumbar Procedures190CARLSBAD, Calif., Aug. 03, 2026 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) ("Carlsmed" or the "Company"), a medical technology company pioneering AI-enabled personalized spine surgery solutions...
► Artikel lesen
1 2 Weiter >>
36 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1